Literature DB >> 2127398

Analysis of the relationship between bacterial adherence and extracellular production of mannose, galactose, glucose and ribose in Staphylococcus epidermidis and Staphylococcus hominis.

P Kotilainen1, P Oksman, M K Viljanen, J Nikoskelainen, P Huovinen.   

Abstract

Gas-liquid chromatography-mass spectrometry was used to analyze the extracellular extracts of 108 coagulase-negative staphylococcal strains for the presence of mannose, galactose, glucose and ribose, in order to determine whether production of these four monosaccharides, regarded as potential staphylococcal slime components, was associated with the adherence capacity of the individuals strains. A total of 90 Staphylococcus epidermidis and 18 Staphylococcus hominis strains were studied. Using the quantitative spectrophotometric assay, 21 Staphylococcus epidermidis strains were classified as strongly adherent, 12 as moderately adherent, 11 as weakly adherent, and 46 as nonadherent. All 18 Staphylococcus hominis strains were nonadherent. Mannose, galactose, glucose and ribose were detected as the main monosaccharide components in the extracellular extracts of all strains examined. Moreover, the mean relative concentrations of these monosaccharides were essentially the same for the different adherence phenotypes within the species Staphylococcus epidermidis. These results showed that there was no causal connection between the adherence of coagulase-negative staphylococci and the extracellular production of any of the four monosaccharides analyzed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127398     DOI: 10.1007/bf01967502

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

2.  Cell wall analysis and taxonomy of staphylococci.

Authors:  F Schumacher-Perdreau; H Rotering; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-11

3.  A model of catheter colonisation in vitro and its relationship to clinical catheter infections.

Authors:  R Bayston
Journal:  J Infect       Date:  1984-11       Impact factor: 6.072

Review 4.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

5.  Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases.

Authors:  S Ponce de Leon; R P Wenzel
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

6.  Investigation on extracellular slime substance produced by Staphylococcus epidermidis.

Authors:  A Ludwicka; G Uhlenbruck; G Peters; P N Seng; E D Gray; J Jeljaszewicz; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1984-12

7.  An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials.

Authors:  R E Chambers; J R Clamp
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

Review 8.  New considerations in the pathogenesis of coagulase-negative staphylococcal foreign body infections.

Authors:  G Peters
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

9.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.